Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Pharmathen S.A., Dervenakion 6, Pallini, Attiki, 153 51, Greece
Consion XL 8 mg prolonged-release capsules, hard.
| Pharmaceutical Form |
|---|
|
Prolonged-release capsule, hard. Opaque white size 2 hard gelatin capsules containing one round biconvex prolonged- release tablet of 8 mg. |
Each 8 mg prolonged-release capsule contains 8 mg galantamine (as hydrobromide).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Galantamine |
Galantamine, a tertiary alkaloid is a selective, competitive and reversible inhibitor of acetylcholinesterase. In addition, galantamine enhances the intrinsic action of acetylcholine on nicotinic receptors, probably through binding to an allosteric site of the receptor. As a consequence, an increased activity in the cholinergic system associated with improved cognitive function can be achieved in patients with dementia of the Alzheimer type. |
| List of Excipients |
|---|
|
Capsule content (Prolonged-release tablets): Cellulose microcrystalline Capsule shell: Gelatin |
Transparent PVC/PE/PVDC – Aluminum blister.
Pack sizes: 7, 28, 30, 56, 84, 98, 100 prolonged-release capsules.
Not all pack sizes may be marketed.
Pharmathen S.A., Dervenakion 6, Pallini, Attiki, 153 51, Greece
PL 17277/0254
16/01/2018
| Drug | Countries | |
|---|---|---|
| CONSION | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
